- Home
- SCOR vs LSTA Comparison
SCOR vs LSTA Comparison
Compare SCOR & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- LSTA
- Stock Information
- Founded
- SCOR 1999
- LSTA 1980
- Country
- SCOR United States
- LSTA United States
- Employees
- SCOR N/A
- LSTA N/A
- Industry
- SCOR Business Services
- LSTA Misc Health and Biotechnology Services
- Sector
- SCOR Consumer Discretionary
- LSTA Health Care
- Exchange
- SCOR Nasdaq
- LSTA Nasdaq
- Market Cap
- SCOR 34.7M
- LSTA 31.2M
- IPO Year
- SCOR 2007
- LSTA N/A
- Fundamental
- Price
- SCOR $6.64
- LSTA $2.55
- Analyst Decision
- SCOR Buy
- LSTA Strong Buy
- Analyst Count
- SCOR 3
- LSTA 1
- Target Price
- SCOR $12.83
- LSTA $15.00
- AVG Volume (30 Days)
- SCOR 27.4K
- LSTA 24.3K
- Earning Date
- SCOR 03-05-2025
- LSTA 02-27-2025
- Dividend Yield
- SCOR N/A
- LSTA N/A
- EPS Growth
- SCOR N/A
- LSTA N/A
- EPS
- SCOR N/A
- LSTA N/A
- Revenue
- SCOR $356,212,000.00
- LSTA N/A
- Revenue This Year
- SCOR N/A
- LSTA N/A
- Revenue Next Year
- SCOR $2.92
- LSTA N/A
- P/E Ratio
- SCOR N/A
- LSTA N/A
- Revenue Growth
- SCOR N/A
- LSTA N/A
- 52 Week Low
- SCOR $4.89
- LSTA $2.19
- 52 Week High
- SCOR $20.42
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- SCOR 43.65
- LSTA 42.39
- Support Level
- SCOR $6.92
- LSTA $2.41
- Resistance Level
- SCOR $7.44
- LSTA $2.66
- Average True Range (ATR)
- SCOR 0.59
- LSTA 0.19
- MACD
- SCOR -0.13
- LSTA 0.01
- Stochastic Oscillator
- SCOR 8.09
- LSTA 42.06
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.